<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Marquez-Garban DC</submitter><funding>California Breast Cancer Research Program</funding><funding>UCLA Jonsson Comprehensive Cancer Center</funding><funding>Hickey Family Foundation</funding><funding>NCI NIH HHS</funding><pagination>2369</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11279598</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(14)</volume><pubmed_abstract>Manuka honey (MH) exhibits potential antitumor activity in preclinical models of a number of human cancers. Treatment in vitro with MH at concentrations ranging from 0.3 to 5.0% (&lt;i>w&lt;/i>/&lt;i>v&lt;/i>) led to significant dose-dependent inhibition of proliferation of human breast cancer MCF-7 cells, but anti-proliferative effects of MH were less pronounced in MDA-MB-231 breast cancer cells. Effects of MH were also tested on non-malignant human mammary epithelial cells (HMECs) at 2.5% &lt;i>w&lt;/i>/&lt;i>v&lt;/i>, and it was found that MH reduced the proliferation of MCF-7 cells but not that of HMECs. Notably, the antitumor activity of MH was in the range of that exerted by treatment of MCF-7 cells with the antiestrogen tamoxifen. Further, MH treatment stimulated apoptosis of MCF-7 cells in vitro, with mos</pubmed_abstract><journal>Nutrients</journal><pubmed_title>Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models.</pubmed_title><pmcid>PMC11279598</pmcid><funding_grant_id>U54 CA143930</funding_grant_id><funding_grant_id>Breast Cancer Research Award</funding_grant_id><funding_grant_id>N.A.</funding_grant_id><funding_grant_id>B27IB3869</funding_grant_id><pubmed_authors>McCloskey SA</pubmed_authors><pubmed_authors>Wadehra M</pubmed_authors><pubmed_authors>Yanes CD</pubmed_authors><pubmed_authors>Hardy M</pubmed_authors><pubmed_authors>Llarena G</pubmed_authors><pubmed_authors>Elashoff D</pubmed_authors><pubmed_authors>Hamilton N</pubmed_authors><pubmed_authors>Pietras RJ</pubmed_authors><pubmed_authors>Marquez-Garban DC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models.</name><description>Manuka honey (MH) exhibits potential antitumor activity in preclinical models of a number of human cancers. Treatment in vitro with MH at concentrations ranging from 0.3 to 5.0% (&lt;i>w&lt;/i>/&lt;i>v&lt;/i>) led to significant dose-dependent inhibition of proliferation of human breast cancer MCF-7 cells, but anti-proliferative effects of MH were less pronounced in MDA-MB-231 breast cancer cells. Effects of MH were also tested on non-malignant human mammary epithelial cells (HMECs) at 2.5% &lt;i>w&lt;/i>/&lt;i>v&lt;/i>, and it was found that MH reduced the proliferation of MCF-7 cells but not that of HMECs. Notably, the antitumor activity of MH was in the range of that exerted by treatment of MCF-7 cells with the antiestrogen tamoxifen. Further, MH treatment stimulated apoptosis of MCF-7 cells in vitro, with mos</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2025-08-27T03:10:55.512Z</modification><creation>2025-08-27T03:10:55.512Z</creation></dates><accession>S-EPMC11279598</accession><cross_references><pubmed>39064812</pubmed><doi>10.3390/nu16142369</doi></cross_references></HashMap>